Name: UMIN ID:
Unique ID issued by UMIN | UMIN000008254 |
---|---|
Receipt number | R000009727 |
Scientific Title | A randomized phase II study investigating an optimal dosing regimen of TS-1 plus CDDP plus Trastuzumab combination therapy for HER2-positive unresectable and/or recurrent gastric cancer |
Date of disclosure of the study information | 2012/06/25 |
Last modified on | 2012/06/25 20:53:40 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/06/25 20:55:01 |